The First Episode Rapid Early Intervention for Eating Disorders - Upscaled study: Clinical outcomes.
anorexia nervosa
bulimia nervosa
early intervention
eating disorder
emerging adulthood
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
02
03
2021
received:
10
10
2020
accepted:
06
03
2021
pubmed:
30
3
2021
medline:
11
3
2022
entrez:
29
3
2021
Statut:
ppublish
Résumé
First Episode Rapid Early Intervention for Eating Disorders (FREED) is a service model and care pathway for emerging adults aged 16 to 25-years with a recent onset eating disorder (ED) of <3 years. A previous single-site study suggests that FREED significantly improves clinical outcomes compared to treatment-as-usual (TAU). The present study (FREED-Up) assessed the scalability of FREED. A multi-centre quasi-experimental pre-post design was used, comparing patient outcomes before and after implementation of FREED in participating services. FREED patients (n = 278) were consecutive, prospectively ascertained referrals to four specialist ED services in England, assessed at four time points over 12 months on ED symptoms, mood, service utilization and cost. FREED patients were compared to a TAU cohort (n = 224) of similar patients, identified retrospectively from electronic patient records in participating services. All were emerging adults aged 16-25 experiencing a first episode ED of <3 years duration. Overall, FREED patients made significant and rapid clinical improvements over time. 53.2% of FREED patients with anorexia nervosa reached a healthy weight at the 12-month timepoint, compared to only 17.9% of TAU patients (X FREED is robust and scalable and is associated with substantial improvements in clinical outcomes, reduction in inpatient or day-patient admissions, and cost-savings.
Sections du résumé
BACKGROUND
First Episode Rapid Early Intervention for Eating Disorders (FREED) is a service model and care pathway for emerging adults aged 16 to 25-years with a recent onset eating disorder (ED) of <3 years. A previous single-site study suggests that FREED significantly improves clinical outcomes compared to treatment-as-usual (TAU). The present study (FREED-Up) assessed the scalability of FREED. A multi-centre quasi-experimental pre-post design was used, comparing patient outcomes before and after implementation of FREED in participating services.
METHODS
FREED patients (n = 278) were consecutive, prospectively ascertained referrals to four specialist ED services in England, assessed at four time points over 12 months on ED symptoms, mood, service utilization and cost. FREED patients were compared to a TAU cohort (n = 224) of similar patients, identified retrospectively from electronic patient records in participating services. All were emerging adults aged 16-25 experiencing a first episode ED of <3 years duration.
RESULTS
Overall, FREED patients made significant and rapid clinical improvements over time. 53.2% of FREED patients with anorexia nervosa reached a healthy weight at the 12-month timepoint, compared to only 17.9% of TAU patients (X
DISCUSSION
FREED is robust and scalable and is associated with substantial improvements in clinical outcomes, reduction in inpatient or day-patient admissions, and cost-savings.
Identifiants
pubmed: 33781000
doi: 10.1111/eip.13139
pmc: PMC9291113
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
97-105Informations de copyright
© 2021 The Authors. Early Intervention in Psychiatry published by John Wiley & Sons Australia, Ltd.
Références
Psychol Med. 2011 Feb;41(2):407-17
pubmed: 20406523
Health Econ. 2011 Aug;20(8):897-916
pubmed: 20799344
Evid Based Ment Health. 2018 Nov;21(4):182-184
pubmed: 30352884
Int J Eat Disord. 2020 Aug;53(8):1337-1348
pubmed: 32064663
BJPsych Open. 2021 May 07;7(3):e98
pubmed: 33958020
Prim Health Care Res Dev. 2018 Jan;19(1):42-52
pubmed: 28829284
BMJ Open. 2019 Dec 5;9(12):e033656
pubmed: 31811012
Early Interv Psychiatry. 2020 Oct;14(5):625-630
pubmed: 32064736
Psychol Med. 2018 Jun;48(8):1228-1256
pubmed: 28889819
J Clin Psychol. 1988 May;44(3):392-7
pubmed: 3384966
Lancet. 2020 Mar 14;395(10227):899-911
pubmed: 32171414
Eur Eat Disord Rev. 2018 Mar;26(2):129-140
pubmed: 29460477
JAMA Psychiatry. 2018 Jun 1;75(6):545-546
pubmed: 29801060
Early Interv Psychiatry. 2018 Apr;12(2):250-257
pubmed: 27619198
Behav Res Ther. 2008 May;46(5):612-22
pubmed: 18359005
Early Interv Psychiatry. 2020 Feb;14(1):137-141
pubmed: 31617325
J Consult Clin Psychol. 2015 Aug;83(4):796-807
pubmed: 25984803
J Eat Disord. 2015 Apr 25;3:19
pubmed: 25914826
Int J Eat Disord. 2015 Dec;48(8):1070-81
pubmed: 26769444
J Eat Disord. 2016 May 18;4:19
pubmed: 27195123
Eur Eat Disord Rev. 2021 May;29(3):329-345
pubmed: 32578311
Early Interv Psychiatry. 2022 Jan;16(1):97-105
pubmed: 33781000
Neurosci Biobehav Rev. 2015 May;52:131-52
pubmed: 25735957
Int J Eat Disord. 2016 Apr;49(4):374-7
pubmed: 27084796
Psychol Med. 2017 Dec;47(16):2823-2833
pubmed: 28552083
Behav Res Ther. 2012 Aug;50(7-8):487-92
pubmed: 22659158
Early Interv Psychiatry. 2015 Jun;9(3):173-84
pubmed: 25263388
Br J Clin Psychol. 2003 Jun;42(Pt 2):111-31
pubmed: 12828802
Eur Eat Disord Rev. 2021 May;29(3):458-471
pubmed: 33112472
Eat Behav. 2017 Jan;24:81-88
pubmed: 28040637
BMC Psychiatry. 2014 Nov 18;14:300
pubmed: 25404427
Int J Eat Disord. 2020 May;53(5):520-531
pubmed: 31999001
Eur Eat Disord Rev. 2021 Mar;29(2):281-291
pubmed: 33421314
Schizophr Bull. 2018 Oct 17;44(6):1362-1372
pubmed: 29373755
Front Behav Neurosci. 2014 Nov 17;8:395
pubmed: 25452718
Br J Psychiatry. 2014 Aug;205(2):88-94
pubmed: 25252316